Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Kangtaijian Pharmaceutical Research Institute is a specialized pharmaceutical research and development organization based in Beijing, China. The institute primarily focuses on the development of high-end generic drugs, formulation innovation, and the consistency evaluation of generic medications to meet modern regulatory standards. It provides a wide range of technical services, including drug synthesis, process optimization, quality control development, and technology transfer to pharmaceutical manufacturers. By bridging the gap between laboratory-scale research and industrial production, the company supports the pharmaceutical industry in enhancing drug quality and manufacturing efficiency. Kangtaijian is recognized for its expertise in navigating the complex regulatory landscape for drug registration and approval in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Kangtaijian Pharmaceutical Research Institute.